A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells - PubMed (original) (raw)
. 2014 Dec;229(12):2106-16.
doi: 10.1002/jcp.24669.
Lavinia Biamonte, Lavinia Raimondi, Domenica Ronchetti, Maria Teresa Di Martino, Cirino Botta, Emanuela Leone, Maria Rita Pitari, Antonino Neri, Antonio Giordano, Pierosandro Tagliaferri, Pierfrancesco Tassone, Nicola Amodio
Affiliations
- PMID: 24819167
- DOI: 10.1002/jcp.24669
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells
Marzia Leotta et al. J Cell Physiol. 2014 Dec.
Abstract
The analysis of deregulated microRNAs (miRNAs) is emerging as a novel approach to disclose the regulation of tumor suppressor or tumor promoting pathways in tumor cells. Targeting aberrantly expressed miRNAs is therefore a promising strategy for cancer treatment. By miRNA profiling of primary plasma cells from multiple myeloma (MM) patients, we previously reported increased miR-125a-5p levels associated to specific molecular subgroups. On these premises, we aimed at investigating the biological effects triggered by miR-125a-5p modulation in MM cells. Expression of p53 pathway-related genes was down-regulated in MM cells transfected with miR-125a-5p mimics. Luciferase reporter assays confirmed specific p53 targeting at 3'UTR level by miR-125a-5p mimics. Interestingly, bone marrow stromal cells (BMSCs) affected the miR-125a-5p/p53 axis, since adhesion of MM cells to BMSCs strongly up-regulated miR-125a-5p levels, while reduced p53 expression. Moreover, ectopic miR-125a-5p reduced, while miR-125-5p inhibitors promoted, the expression of tumor suppressor miR-192 and miR-194, transcriptionally regulated by p53. Lentiviral-mediated stable inhibition of miR-125a-5p expression in wild-type p53 MM cells dampened cell growth, increased apoptosis and reduced cell migration. Importantly, inhibition of in vitro MM cell proliferation and migration was also achieved by synthetic miR-125a-5p inhibitors and was potentiated by the co-expression of miR-192 or miR-194. Taken together, our data indicate that miR-125a-5p antagonism results in the activation of p53 pathway in MM cells, underlying the crucial role of this miRNA in the biopathology of MM and providing the molecular rationale for the combinatory use of miR-125a inhibitors and miR-192 or miR-194 mimics for MM treatment.
© 2014 Wiley Periodicals, Inc.
Similar articles
- Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
Gao W, Chan JY, Wong TS. Gao W, et al. Clin Sci (Lond). 2014 Nov;127(9):571-9. doi: 10.1042/CS20140010. Clin Sci (Lond). 2014. PMID: 24896104 - MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells.
Jiang L, Huang Q, Chang J, Wang E, Qiu X. Jiang L, et al. Exp Lung Res. 2011 Sep;37(7):387-98. doi: 10.3109/01902148.2010.492068. Epub 2011 Jul 21. Exp Lung Res. 2011. PMID: 21777146 - MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
Huang B, Luo W, Sun L, Zhang Q, Jiang L, Chang J, Qiu X, Wang E. Huang B, et al. Int J Oncol. 2013 May;42(5):1734-42. doi: 10.3892/ijo.2013.1861. Epub 2013 Mar 21. Int J Oncol. 2013. PMID: 23525486 - Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS, Selemon H, Elton SM, Parinandi NL. Elton TS, et al. Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Gene. 2013. PMID: 23246696 Review. - The p53/microRNA network in cancer: experimental and bioinformatics approaches.
Hünten S, Siemens H, Kaller M, Hermeking H. Hünten S, et al. Adv Exp Med Biol. 2013;774:77-101. doi: 10.1007/978-94-007-5590-1_5. Adv Exp Med Biol. 2013. PMID: 23377969 Review.
Cited by
- Beneficial Effect of Olive Oil and Its Derivates: Focus on Hematological Neoplasm.
Campo C, Gangemi S, Pioggia G, Allegra A. Campo C, et al. Life (Basel). 2024 Apr 30;14(5):583. doi: 10.3390/life14050583. Life (Basel). 2024. PMID: 38792604 Free PMC article. Review. - Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.
Sevcikova A, Fridrichova I, Nikolaieva N, Kalinkova L, Omelka R, Martiniakova M, Ciernikova S. Sevcikova A, et al. Cancers (Basel). 2023 May 8;15(9):2658. doi: 10.3390/cancers15092658. Cancers (Basel). 2023. PMID: 37174123 Free PMC article. Review. - Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma.
Alipoor SD, Chang H. Alipoor SD, et al. Cells. 2023 Mar 28;12(7):1030. doi: 10.3390/cells12071030. Cells. 2023. PMID: 37048103 Free PMC article. Review. - MiRNA as a Potential Target for Multiple Myeloma Therapy-Current Knowledge and Perspectives.
Szudy-Szczyrek A, Ahern S, Krawczyk J, Szczyrek M, Hus M. Szudy-Szczyrek A, et al. J Pers Med. 2022 Aug 31;12(9):1428. doi: 10.3390/jpm12091428. J Pers Med. 2022. PMID: 36143213 Free PMC article. Review. - Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction.
Gandhi M, Bakhai V, Trivedi J, Mishra A, De Andrés F, LLerena A, Sharma R, Nair S. Gandhi M, et al. Transl Oncol. 2022 Nov;25:101532. doi: 10.1016/j.tranon.2022.101532. Epub 2022 Sep 11. Transl Oncol. 2022. PMID: 36103755 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous